Portfolio
Overview

Watchlist
Overview


more

Portfolios Overview New Portfolio
Demo Portfolio
$75,350.00
Total Gain % 149.43%
Total Gain $25,350.00
Total Realised % 0.00%
Total Realised $0.00
Back
Watchlists Overview New Watchlist
Targets
33 Average Rating
Number of Companies 3
Date Created 04 Mar, 2015
Back
Portfolio Summary
Demo Portfolio
Market Value $75,350.00
Total Gain $25,350.00
(149.43%)
Value $42,315.00
Close Price (13 Apr) $141.05
Unrealised P/L (%) 149.40%
Unrealised P/L $25,350.00
Total $75,350.00
$25,350.00
Back
Back
Watchlist Summary
Targets
Short Name TGTS
Date Created 04 Mar, 2015
Current Price $64.95
Added Price $43.06
STRIDE Rating 36
Value Change (%) 50.85%
Current Price $33.88
Added Price $34.64
STRIDE Rating 25
Value Change (%) -2.19%
Current Price $26.74
Added Price $29.27
STRIDE Rating 35
Value Change (%) -8.63%
Total Buy0
Total Hold0
Total Sell3
Back
Back
Filter
Include in Feed
My Portfolios
My Watchlists
STRIDE Lists
Filter Feed By
STRIDE 3D VI
Activity
Upcoming
Warning
Back
Company FilterClear All
Filter by Company Descriptions
Filter by STRIDE Scores
Strength
to
Timing
to
Returns
to
Intrinsic Value
to
Dividends
to
Earnings Predictability
to
Rating
to
Back
Options
Add To Watchlist
Company Info (Sample)
Options
Add To Watchlist

AbbVie Inc.

AbbVie Inc.
Pharmaceuticals, Biotechnology and Life Sciences : Biotechnology.
ABBV on New York Stock Exchange.
Price in US Dollar, all financial data originally reported in US Dollar.
Founded in 2012, the business is 5 years old.
The business last filed accounts on the 17 Feb, 2017.
Company website: www.abbvie.com
Show Company Details
STRIDE Rating
00
Buy
Hold
Sell
United States, Large Cap
Market Capitalisation: $104,596.03M
Total Enterprise Value: Get a demo
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company offers HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; IMBRUVICA, an oral therapy for the treatment of patients with chronic lymphocytic leukemia; and VIEKIRA PAK, an interferon-free therapy, with or without ribavirin, for the treatment of adults with genotype 1 chronic hepatitis C. It also provides Kaletra, an anti- human immunodeficiency virus(HIV)-1 medicine used with other anti-HIV-1 medications as a treatment that maintains viral suppression in HIV-1 patients; Norvir, a protease inhibitor indicated in combination with other antiretroviral agents to treat HIV-1; and Synagis to prevent RSV infection at-risk infants. In addition, the company offers AndroGel, a testosterone replacement therapy for males diagnosed with symptomatic low testosterone; Creon, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid to treat hypothyroidism; and Lupron, a product for the palliative treatment of prostate cancer, endometriosis, and central precocious puberty, as well as for the treatment of patients with anemia. Further, it provides Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson’s disease; Sevoflurane, an anesthesia product for human use; and ZINBRYTA, a subcutaneous treatment for relapsing forms of multiple sclerosis. The company sells its products to wholesalers, distributors, government agencies, health care facilities, specialty pharmacies, and independent retailers from its distribution centers and public warehouses. AbbVie Inc. has collaboration agreements with C2N Diagnostics; Calico Life Sciences LLC; Infinity Pharmaceuticals, Inc.; and M2Gen. The company was incorporated in 2012 and is based in North Chicago, Illinois. Read More
Company Feed
Price & Valuation Info
Price Quote on 13th Apr '17
$64.13 -0.24(-0.37%)
52 Week Range
55.06
68.12
Interactive STRIDE chart with history.
Only available to subscribers.
Get a demo now.
Performance
1 month -1.54 (-2.35%)
year-to-date 1.51 (2.41%)
1 year 4.62 (7.76%)
Show More Valuation Info
Momentum
vs 52week high 94%
vs 50d SMA 101%
vs 200d SMA102%
STRIDE Valuations
Consider Buy Get a demo
Fair Value Get a demo
Consider Sell Get a demo
Price/Adj. Earnings Get a demo
Price/Adj FCF Get a demo
Price/Adj. TBV Get a demo
Forecast Growth Get a demo
Other Valuations
Price/Book Get a demo
Price/Tangible Book Get a demo
Price/Sales Get a demo
Price/Earnings Get a demo
Price/Free Cashflow Get a demo
EV/EBITDA Get a demo
Dividend Yield Get a demo
Volume
Ave. Vol. last 6 months
Hide Extra Info
Scores
S
Strength
T
Timing
R
Returns
I
Intrinsic Value
D
Dividends
E
Earnings Predictability
Other Metrics
Altman Z-Score (Bankruptcy)
Greenblatt Rank (Magic Formula)
Piotroski F-Score (Financial Health)
Beneish M-Score (Earnings Manipulation)
Financials Get a demo
To The Top
Company Options
Add To Watchlist
Watchlists:
Targets
Options
Price Alert Email:
Price to alert at:*
When to alert:*
Cancel
Save
Price Alerts Configured:
Back

Portfolio
Overview

Watchlist
Overview

Feed
Filter


more